VenomAid Diagnostics ApS

CVR 39981165 · Private limited company (ApS) · Active · Medium risk

VenomAid Diagnostics ApS is a Private limited company (ApS), founded on , based in Kongens Lyngby. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.3% over the next 12 months, which is 1.6 times the average for Danish companies. 7 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -11.3m and a net result of DKK -3.9m. CEO: Jonas Arnold Jürgensen-Breum.

Bankruptcy risk for VenomAid Diagnostics ApS

2.3%
probability of bankruptcy within 12 months
Medium risk

1.6 × the average (1.41%) · higher risk than 84% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Registered owners4+ · bankruptcy rate 5.7%0.65×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Auditor's statementAudit · bankruptcy rate 5.8%0.66×
Has a boardYes · bankruptcy rate 6.0%0.68×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
39981165
Status
Active
Company type
Private limited company (ApS)
Founded
(8 years)
Address
Søltofts Plads 224, 1.
2800 Kongens Lyngby
Municipality
Lyngby-Taarbæk
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 50k
Auditor
BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB
Audit opted out
No

Warning signs

Annual reports filed late2 of 7
Missing annual reportNo
Negative equityYes
Equity ratio-220.0%
Current ratio1,620%
Moves (last 2 years)1
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -867kDKK -603k
Net profitDKK -3.9mDKK -3.7m
EquityDKK -11.3mDKK -7.4m
Total assetsDKK 5.1mDKK 7.6m
CashDKK 4.1m–
Short-term debtDKK 310k–
Avg. employees5–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Baagøe | Schou, statsautoriseret revisionsaktieselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025176
1 Jan 2024 – 31 Dec 2024170
1 Jan 2023 – 31 Dec 2023171
1 Jan 2022 – 31 Dec 2022171
1 Jan 2021 – 31 Dec 2021186 Late
1 Jan 2020 – 31 Dec 2020136
29 Oct 2018 – 31 Dec 2019232 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOJonas Arnold Jürgensen-BreumCurrent
CEORasmus Aasbjerg Friis
BoardMads Aage LaustsenCurrent
BoardAndreas Hougaard Laustsen-KielCurrent
BoardGert Fisker TomczykCurrent
BoardMorten Boje MunkCurrent
Owner (5%)Ubia Holdings ApSCurrent
Owner (20%)LAUSTSEN VENTURES ApSCurrent
Owner (33%)Moleculo Holdings ApSCurrent
Owner (10%)Sirius Ventures ApSCurrent
Owner (15%)LAUSTSEN VENTURES ApS
Owner (25%)Moleculo Holdings ApS
Owner (25%)Sirius Ventures ApS
Owner (5%)RF Ventures ApS
Owner (5%)Ortus Holdings ApS
AuditorBAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKABCurrent
FounderLAUSTSEN VENTURES ApSCurrent
FounderMoleculo Holdings ApSCurrent
FounderUbia Holdings ApSCurrent
FounderSirius Ventures ApSCurrent
FounderRF Ventures ApSCurrent
FounderOrtus Holdings ApSCurrent

The CEOs' other companies

Jonas Arnold Jürgensen-Breum – 1 other companies

Address history (3 moves)

Søltofts Plads 224, 1., 2800 Kongens Lyngby
Kolonnevej 239, st., 2800 Kongens Lyngby
c/o Futurebox, Elektrovej 331, 2800 Kongens Lyngby
Rungsted Plads 10, st. th, 2200 København N

Other companies at the same address

Similar companies in Lyngby-Taarbæk

Questions and answers about VenomAid Diagnostics ApS

Has VenomAid Diagnostics ApS gone bankrupt?

No, VenomAid Diagnostics ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of VenomAid Diagnostics ApS?

Our model estimates a bankruptcy risk of 2.3% over the next 12 months (medium risk), which is 1.6 times the average for Danish companies.

Who is the CEO of VenomAid Diagnostics ApS?

Jonas Arnold Jürgensen-Breum is the CEO of VenomAid Diagnostics ApS.

Who is the auditor of VenomAid Diagnostics ApS?

VenomAid Diagnostics ApS most recently used BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB.

When was VenomAid Diagnostics ApS founded?

VenomAid Diagnostics ApS was founded on 29 October 2018.

What is the equity of VenomAid Diagnostics ApS?

Equity was DKK -11.3m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.